|
Τίτλος – Title
|
Transmission Index of Tuberculosis in Students: an exposure investigation in Cyprus |
|
|
Συγγραφέας – Author
|
Zoe Roupa, Monica Nikitara, Savoulla Ghobrial, Evaggelos Lantzourakis, Maria Pitsillidou, Antonis Stylianides, Giannis Polychronis Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus |
|
|
Παραπομπή – Citation
|
Z. Roupa, M. Nikitara, S. Ghobrial, E. Lantzourakis, M. Pitsillidou, A. Stylianides, G. Polychronis. Transmission Index of Tuberculosis in Students: an exposure investigation in Cyprus. Review Clin. Pharmacol. Pharmacokinet. 2021, 35, 2, 59-65 |
|
|
Ημερομηνία Δημοσιευσης – Publication Date
|
22-06-2021
|
|
|
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Αγγλικά – English |
|
|
Λέξεις κλειδιά – Keywords
|
Transmission Index of Tuberculosis in Students: an exposure investigation in Cyprus
|
|
|
Λοιποί Όροι – Other Terms
|
Μελέτη |
|
|
Περίληψη – Summary
|
Presently, Tuberculosis continues to remain a global health problem. Tuberculosis can affect people of all ages, mainly occurring in developing countries. The present study aims to investigate the TB infection rate in Cyprus within a convenience sample of students at a University in Cyprus. The majority of participants showed a negative result in the Mantoux test whilst only 3 participants (1.9 %) presented a positive result. As observed in the current study, the majority of par-ticipants were not vaccinated against tuberculosis. Possibly, an effective strategy in controlling the spread of the disease would be to conduct a Mantoux test only in people originating from high-load countries. | |
| Αναφορές – References | 1. Zerling A, Behr A. B., Verma A., Brewer T., Men-zies D., Pai M.: “The BCG World Atlas: A Data-base of Global BCG Vaccination Policies and Practices,” PLoS Med, vol. 8, no. 3, p. e1001012, (2011) 2. Evans T. G., Brennan M. J., Barker L., and Thole J.: “Preventive vaccines for tuberculo-sis,” Vaccine, vol. 31, p. B223-B226, (2013) 3. WHO, “Global tuberculosis report 2019,” World Health Organization, Geneva, (2019) 4. WHO, “WHO guidelines on tuberculosis infec-tion prevention and control, 2019 update,” World Health Organization; Geneva, (2019) 5. Rowland R., McShane H.: “Tuberculosis vac-cines in clinical trials,” Expert Rev Vaccines, vol. 10, no. 5, p. 645–658, (2011) 6. Temeris, M. D., Hatherill, M., Landry, B. S., Scriba, T. J., Snowden, M. A., Lockhart, S., et al.:”Safety and efficacy of MVA85A, a new tu-berculosis vaccine, in infants previously vac-cinated with BCG: a randomised, placebo-controlled phase 2b trial,” Lancet, vol. 381, p. 1021–1018, (2013) 7. McShane Η.: “Tuberculosis Vaccines: Beyond Bacille Calmette-Guerin,” Philos Trans R Soc Lond B Biol Sci, vol. 366, no. 1579, pp. 2782-9, (2011) 8. Dara, M., Acosta, C. D., Rusovich, V., Zellweger, J. P., Centis, R., Migliori, G. B., & WHO EURO Childhood Task Force members: “Bacille Calmette-Guérin Vaccination: The Cur-rent Situation in Europe,” Eur Respir J, vol. 1, pp. 24-35, (2014) 9. Harahap F, Daulay R. M, Ali M., Dalimunthe W., Daula R. S.: “Mantoux test results and BCG vaccination status in TB-exposed children,” Paediatrica Indonesiana, vol. 55, no. 1, pp. 7-12, (2015) 10. Nayak S., Acharjya B.: “Mantoux test and its interpretation,” Indian Dermatol Online J, vol. 3, no. 1, p. 2-6, (2012) 11. WHO, “The use of bedaquiline in the treatment of multidrug-resistant tuberculosis,” World Health Organization, Geneva, (2013) 12. Karentzas C. A., Jacobs W. R.: “Origins of Combination Therapy for Tuberculosis: Les-sons for Future Antimicrobial Development and Application,” mBio, vol. 8, pp. e01586-16, (2017) 13. Loh Κ. Υ.:”Role of Mantoux Test in the Diagno-sis of Tuberculosis,” Malaysian Family Physi-cian, vol. 6, no. 2 & 3, pp. 85-86, (2011) 14. Anjum R., Qayum S., Rashid A.: “Evaluation of BCG test in diagnosis of tuberculosis in BCG vaccinated children and its comparison with Mantoux test,” Int J Contemp Pediatr, vol. 3, no. 4, pp. 1339-1343, (2016) 15. Stewart R. J., Tsang C. A., Pratt R. H., Price S. F., Langer A. J.: “Tuberculosis — United States, 2017,” MMWR Morb Mortal Wkly Rep, vol. 67, p. 317–323, (2018) 16. Lan H. L., McMurray N. D.: “Tuberculosis: vac-cines in the pipeline,” Expert Review of Vac-cines, vol. 7, no. 5, pp. 635-650, (2008) 17. Soysal , Α., Millington, Κ. Α., Mustafa , Β., Dosanjh, D., Aslan, Y., Deeks, J. et al.:”Effect of BCG vaccination on risk of Mycobacterium tu-berculosis infection in children with house-hold tuberculosis contact: a prospective com-munity-based study,” Lancet, vol. 366, no. 9495, pp. 1443-1451, (2005) 18. Eisenhut , M., Paranjothy, S., Abubakar, I., Bracebridge, S., Lilley, M., Mulla, R., McEvoy, M.:”BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay,” Vaccine, vol. 27, no. 44, p. 6116-6120, (2009) 19. Basu, R. R., Sotgiu, G., Altet-Gomez, N., Tsolia, M., Ruga, E., Velizarova, S., & Kampmann, B.:”Identifying predictors of interferon-γ re-lease assay results in pediatric latent tubercu-losis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study,” Am J Respir Crit Care Med, vol. 186, no. 4, p. 378‐384, (2012) 20. Roy , A., Eisenhut , M., Harris , R. J., Rodrigues, L. C., Sridhar , S., Habermann , I. Abubakar I.: “Effect of BCG vaccination against Mycobacterium tuberculosis infection in chil-dren: systematic review and meta-analysis,” BMJ, vol. 349, p. g4643, (2014) 21. Rodrigues L, Pereira S, Cunha S, Genser B, Ichihara M, de Brito S et al. Effect of BCG re-vaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. The Lan-cet.;366(9493):1290-1295. (2005) 22. Barreto M, Pereira S, Pilger D, Cruz A, Cunha S, Sant’Anna C et al. Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: Second report of the BCG-REVAC cluster-randomised trial. Vaccine.;29(31):4875-4877. (2011) 23. Abubakar I., Pimpin L., Ariti C., Beynon R., Mangtan P., Sterne J. A., Fine P. E., Smith P. G., Lipman M., Elliman D., Watson J. M.,Drumright L. N., Whiting P. F., Vynnycky E., Rodriques L. C.: “Systematic Review and Meta-Analysis of the Current Evidence on the Dura-tion of Protection by Bacillus Calmette-Guérin Vaccination Against Tuberculosis,” Health Technol Assess, vol. 17, pp. 1-372, (2013) 24. Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine P et al. Protection by BCG Vac-cine Against Tuberculosis: A Systematic Re-view of Randomized Controlled Trials. Clinical Infectious Diseases. ;58(4):470-480, (2013) 25. WHO, “BCG vaccine. WHO position paper.,” Wkly Epidemiol Rec, vol. 79, p. 27–38, (2004) 26. Infuso A., Falzon D.: On Behalf Of The Euro-Tb Network, “European survey of BCG vaccina-tion policies and surveillance in children,” Eu-ro Surveill, vol. 11, no. 3, p. 604, 2006. 27. Bansal R., Sharma P. K.: “Εxaggerated Μan-toux reaction in a case of latent tuberculosis infection (LTBI),” Indian J Tuberc, vol. 59, pp. 171-173, (2012) |
|
|
Σχετικές Εργασίες – Relative Papers
|
Online ISSN 1011-6583
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Τι είναι η Review of Clinical Pharmacology and Pharmacokinetics-Διεθνής Έκδοση-Οδηγίες προς τους Συγγραφείς
What is Review of Clinical Pharmacology and Pharmacokinetics-International Edition-Instrunctions to Authors
Άρθρα Δημοσιευμένα στην Review of Clinical Pharmacology and Pharmacokinetics-Διεθνής Έκδοση
Articles Published in Review of Clinical Pharmacology and Pharmacokinetics-International Edition
Συντακτικη Επιτροπή-Editorial Board